Kanada - Englisch - Health Canada

paladin labs inc. - clioquinol; flumethasone pivalate - cream - 3%; 0.02% - clioquinol 3%; flumethasone pivalate 0.02% - anti-inflammatory agents

Kanada - Englisch - Health Canada

paladin labs inc. - clioquinol; hydrocortisone - cream - 3%; 1% - clioquinol 3%; hydrocortisone 1% - anti-inflammatory agents

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - clioquinol; flumetasone pivalate - ear drops - 10mg/1ml ; 200microgram/1ml

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - clioquinol; flumetasone pivalate - ear drops - 10mg/1ml ; 200microgram/1ml

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

reig jofre uk ltd - clioquinol; fluocinolone acetonide - cutaneous ointment - 30mg/1gram ; 250microgram/1gram

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

chemidex pharma ltd - betamethasone valerate; clioquinol - cutaneous cream - 1mg/1gram ; 30mg/1gram

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - flumetasone pivalate, quantity: 0.2 mg/ml; clioquinol, quantity: 10 mg/ml - ear drops - excipient ingredients: macrogol 300 - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. new indications were approved as specified in the letter of 29 june 1992 from dr alex proudfoot. indicated for the treatment of eczema of the external auditory meatus in which secondary infection with micro-organisms sensitive to clioquinol has occurred. otitis externa. otomycosis.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - betamethasone; clioquinol - cream - 0.1 %w/w + 3.0 percent weight/weight - corticosteroids, potent, combinations with antiseptics; betamethasone and antiseptics

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative}; clioquinol 3%{relative};   - topical cream - 0.1%/3% - active: betamethasone valerate 0.1%{relative} clioquinol 3%{relative}   - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.

Philippinen - Englisch - FDA (Food And Drug Administration)

lloyd labs inc - betamethasone valerate , gentamicin sulfate , tolnaftate , clioquinol - cream, topical - 500mcg + 1mg + 10mg + 10mg pergram